When can my child stop taking Kalydeco?

Your child's doctor may not want him to stop taking Kalydeco (ivacaftor), a long-term treatment for cystic fibrosis (CF). It is approved for children over age 6 as well as adults who have a certain mutation in their CF gene called the G551D mutation, which occurs in about 4% of people with CF.

In people with this mutation, Kalydeco treats the underlying cause of CF. Your child's doctor may want your child to continue taking Kalydeco to help keep his symptoms under control.

Continue Learning about Respiratory Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.